Kexing Biopharm Co., Ltd. (SHA:688136)

Kexing Biopharm Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,664	4,323	4,034	4,260	5,617	8,115
Market Cap Growth	72.28%	7.17%	-5.31%	-24.16%	-30.78%	-
Enterprise Value	7,452	5,012	4,566	4,432	5,203	8,278
Last Close Price	33.64	21.83	20.22	21.41	28.13	40.55
PE Ratio	54.28	137.32	-	-	58.23	58.32
PS Ratio	4.40	3.07	3.20	3.24	4.37	6.65
PB Ratio	3.88	2.64	2.47	2.36	2.94	4.43
P/TBV Ratio	4.51	3.07	2.75	2.59	2.98	4.53
P/FCF Ratio	-	340.98	-	-	-	-
P/OCF Ratio	144.43	40.53	-	-	59.75	76.61
EV/Sales Ratio	4.91	3.56	3.63	3.37	4.05	6.78
EV/EBITDA Ratio	36.41	27.15	-	-	67.21	39.86
EV/EBIT Ratio	77.73	50.87	-	-	123.25	46.36
EV/FCF Ratio	-238.50	395.29	-	-	-	-
Debt / Equity Ratio	0.82	0.75	0.68	0.57	0.32	0.17
Debt / EBITDA Ratio	6.83	6.18	-	-	6.53	1.52
Debt / FCF Ratio	-	96.29	-	-	-	-
Asset Turnover	0.47	0.45	0.41	0.44	0.50	0.69
Inventory Turnover	4.13	2.67	1.85	1.71	1.86	1.95
Quick Ratio	1.36	1.28	1.37	2.18	2.09	3.44
Current Ratio	1.50	1.45	1.69	2.62	2.42	3.73
Return on Equity (ROE)	7.34%	1.65%	-11.38%	-5.00%	5.16%	11.01%
Return on Assets (ROA)	1.87%	1.99%	-4.86%	-2.61%	1.02%	6.29%
Return on Invested Capital (ROIC)	3.89%	2.09%	-11.36%	-6.79%	3.15%	16.79%
Return on Capital Employed (ROCE)	4.00%	4.30%	-10.20%	-4.80%	1.90%	9.30%
Earnings Yield	1.88%	0.73%	-4.72%	-2.12%	1.72%	1.71%
FCF Yield	-0.47%	0.29%	-6.90%	-11.39%	-4.95%	-1.02%
Dividend Yield	0.24%	0.37%	-	-	0.36%	0.20%
Payout Ratio	45.28%	138.60%	-	-	29.43%	7.81%
Buyback Yield / Dilution	-6.36%	0.74%	1.21%	-1.93%	-31.59%	-0.17%
Total Shareholder Return	-6.13%	1.10%	1.21%	-1.93%	-31.23%	0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.